(See all Brian Wigdahl's publications in PubMed.)
"Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1"
Pirrone V, Passic SR, Wigdahl B, and FC Krebs
Virology Journal, 9(1): 33, 2012
"Macrophage colony stimulating factor regulation by nuclear factor kappa B: A relevant pathway in human immunodeficiency virus type 1 infected macrophages"
Kogan M, Haine V, Ke Y, Wigdahl B, Fischer-Smith T, and J Rappaport
DNA and Cell Biology, 31(3): 278-288, 2012
"Extracellular human immunodeficiency virus type 1 viral protein R causes a reduction in ATP and glutathione levels in an astrocytic cell line resulting in a compromised antioxidant reservoir"
Ferrucci A, Nonnemacher MR, Cohen EA, and B Wigdahl
Virus Research, 167(2): 358-369, 2012
"Deployment of the HIV-1 protein arsenal: Combatingthe host to enhance viral transcription and providing targets for therapeutic development"
Dahiya S, Nonnemacher MR, and B Wigdahl
J. General Virology, 93: 1151-1172, 2012
"Impact of Tat genetic variation on HIV-1 disease"
Li L, Dahiya S, Kortagere S, Cunningham D, Pirrone V, Nonnemacher M, and B Wigdahl
Advances in Virology, Volume 2012, Article ID 123605, 2012
"Substance abuse, HIV-1 and hepatitis"
Parikh N, Nonnemacher MR, Pirrone V, Block T, Mehta A, and B Wigdahl
Current HIV Research, 10(7): 557-571, 2012
"Human immunodeficiency virus viral protein R as an extracellular protein in neuropathogenesis"
Ferrucci A, Nonnemacher MR, and B Wigdahl
Advances in Viral Research, 81: 165-199, 2011
"Role of Mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis"
Banerjee A, Strazza M, Wigdahl B, Pirrone V, Meucci O, and Nonnemacher MR
Journal of Neurovirology, 17(4):291-302, 2011
"Cellular phenotype impacts human immunodeficiency virus type 1 viral protein R subcellular localization"
Ferrucci A, Nonnemacher MR and Wigdahl B
Virology Journal, 8(1):397, 2011
"Transcriptional regulation of the chemokine co-receptor CCR5 by the cAMP/PKA/CREB pathway"
Banerjee A, Pirrone V, Wigdahl B, and Nonnemacher M
Biomedicine and Pharmacotherapy, 65(4):293-297, 2011
"Breaking Down the Barrier: The effects of HIV-1 on the blood-brain barrier"
Strazza M, Pirrone V, Wigdahl B, and Nonnemacher M
Brain Research, 1399:96-115, 2011
"Combinatorial approaches to the prevention and treatment of HIV-1 infection"
Pirrone V, Thakkar-Rivera N, Jacobson J, Wigdahl B, and Krebs FC
Antimicrobial Agents and Chemotherapy, 55(5):1831-1842, 2011
"Development of co-selected single nucleotide polymorphisms in the viral promoter procedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment"
Li L, Aiamkitsumrit B, Pirrone V, Nonnemacher M, Wojno A, Passic S, Flaig K, Kilareski E, Blakey B, Ku J, Parikh N, Shah R, Martin-Garcia J, Moldover B, Servance L, Downie D, Lewis S, Jacobson JM, Kolson D, and Wigdahl B
Journal of NeuroVirology, 17:92-109, 2011
"Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection"
Rahman S, Khan ZK, Wigdahl B, Jennings SR, Tangy F, and Jain P
Journal of Immunology, 186(1):390-402, 2011